NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 69097-0522-35 — Isoproterenol 0.2 mg/mL injectionAI (171 hospitals, 49,263–50,145 samples)
• NDC 00338-0424-18 — Heparin in sodium chloride IV solutionAI (353 hospitals, 47,400–50,145 samples)
• NDC 69918-0735-01 — Isoproterenol hydrochloride injectionAI (291 hospitals, 49,101–50,109 samples)
• NDC 00074-1040-04 — Beractant intratracheal suspensionAI (215 hospitals, 49,116–50,088 samples)
• NDC 00409-4093-01 — Chromic chloride intravenous solutionAI (310 hospitals, 49,184–50,075 samples)
• NDC 63323-0186-03 — Preservative-free sodium chloride 0.9% injectionAI (216 hospitals, 45,098–50,048 samples)
• NDC 00409-9094-16 — Fentanyl citrate injection, 1000 mcg per 20 mLAI (312 hospitals, 42,757–50,047 samples)
• NDC 00409-4093-11 — Chromium chloride trace mineral IV solutionAI (131 hospitals, 49,131–49,977 samples)
• NDC 67457-0198-03 — remifentanil 1 mg intravenous solutionAI (326 hospitals, 48,495–49,971 samples)
• NDC 08065-1830-85 — Sodium hyaluronate eye injection syringeAI (331 hospitals, 48,775–49,963 samples)
• NDC 65219-0052-29 — Potassium phosphate intravenous solutionAI (470 hospitals, 48,996–49,959 samples)
• NDC 00703-1153-01 — Norepinephrine 1 mg/mL intravenous solutionAI (145 hospitals, 49,145–49,946 samples)
• NDC 67457-0925-10 — Dexmedetomidine IV infusion in salineAI (180 hospitals, 49,081–49,927 samples)
• NDC 67457-0925-00 — Dexmedetomidine IV infusion in salineAI (116 hospitals, 49,081–49,927 samples)
• NDC 00703-2045-03 — Cisatracurium injection 10 mg/mL (ICU use)AI (103 hospitals, 49,081–49,927 samples)
• NDC 00703-2045-01 — Cisatracurium injection for intravenous use in ICUAI (106 hospitals, 49,081–49,927 samples)
• NDC 50419-0325-09 — Gadobutrol injection, intravenous contrastAI (55 hospitals, 47,862–49,923 samples)
• NDC 00409-1555-64 — Hetastarch in lactated electrolyte IV solutionAI (106 hospitals, 49,116–49,890 samples)
• NDC 00703-1153-81 — Norepinephrine 1 mg/mL intravenous solutionAI (41 hospitals, 49,066–49,858 samples)
• NDC 46287-0024-10 — Potassium phosphate intravenous solutionAI (174 hospitals, 49,071–49,827 samples)
• NDC 00409-3670-01 — Cisatracurium injection 10 mg/mL (ICU use)AI (68 hospitals, 49,071–49,827 samples)
• NDC 69784-0205-30 — Cromolyn sodium nebulizer solution, 20 mg per 2 mLAI (55 hospitals, 49,071–49,827 samples)
• NDC 69784-0840-05 — Selenium injection solutionAI (79 hospitals, 49,071–49,827 samples)
• NDC 00409-1634-85 — Vecuronium bromide 20 mg intravenous injectionAI (48 hospitals, 49,071–49,827 samples)
• NDC 14789-0015-05 — Isoproterenol 0.2 mg/mL solution, 5 mL vialAI (510 hospitals, 48,898–49,816 samples)
• NDC 63323-0724-05 — Remifentanil 2 mg IV solutionAI (307 hospitals, 49,033–49,789 samples)
• NDC 67457-0421-00 — Dexamethasone sodium phosphate 4 mg/mL injectionAI (222 hospitals, 44,768–49,781 samples)
• NDC 00574-2008-15 — Nystatin topical powderAI (751 hospitals, 48,132–49,734 samples)
• NDC 00409-1660-10 — Dexmedetomidine IV infusion in salineAI (301 hospitals, 48,822–49,713 samples)
• NDC 67157-0101-50 — Vitamin C injection, 50 mL vialAI (770 hospitals, 48,603–49,710 samples)
• NDC 25021-0310-02 — Sodium nitroprusside intravenous solutionAI (301 hospitals, 48,828–49,683 samples)
• NDC 00264-7610-00 — Dextrose and saline intravenous fluidAI (452 hospitals, 48,401–49,670 samples)
• NDC 49502-0101-02 — Epinephrine auto-injector 0.15 mgAI (489 hospitals, 47,829–49,629 samples)
• NDC 00338-0023-02 — Dextrose 10% injectionAI (671 hospitals, 46,841–49,559 samples)
• NDC 70069-0151-10 — Cisatracurium muscle relaxant injection for ICU useAI (295 hospitals, 48,731–49,496 samples)
• NDC 00409-4888-50 — Preservative-free sodium chloride 0.9% injectionAI (358 hospitals, 46,133–49,454 samples)
• NDC 51754-1007-01 — L-cysteine injection solution vialAI (354 hospitals, 48,403–49,438 samples)
• NDC 24338-0050-08 — Carmustine 7.7 mg wafer (implant)AI (344 hospitals, 48,548–49,403 samples)
• NDC 65219-0052-09 — Potassium phosphate intravenous solutionAI (412 hospitals, 48,279–49,377 samples)
• NDC 00065-0741-14 — Tetracaine eye dropsAI (1148 hospitals, 47,396–49,376 samples)
• NDC 23155-0600-31 — Midazolam 1 mg/mL injectionAI (568 hospitals, 41,095–49,339 samples)
• NDC 14789-0015-07 — Isoproterenol injectionAI (316 hospitals, 48,344–49,298 samples)
• NDC 67457-0198-05 — Remifentanil 2 mg vialAI (329 hospitals, 48,605–49,280 samples)
• NDC 51754-1007-03 — Cysteine hydrochloride intravenous solutionAI (405 hospitals, 48,180–49,206 samples)
• NDC 00781-3153-80 — Cisatracurium 10 mg/mL injection for intravenous useAI (173 hospitals, 48,180–49,206 samples)
• NDC 00517-0375-05 — Indigo carmine dye injection (indigotindisulfonate sodium)AI (304 hospitals, 48,497–49,190 samples)
• NDC 00517-0960-01 — Tranexamic acid 1,000 mg intravenous solutionAI (167 hospitals, 48,274–49,138 samples)
• NDC 00409-1113-01 — INDOMETHACIN 1 MG INTRAVENOUS SOLUTIONAI (110 hospitals, 48,511–49,114 samples)
• NDC 00517-0375-01 — Indigotindisulfonate sodium injection solutionAI (124 hospitals, 48,191–49,010 samples)
• NDC 00019-1333-06 — Ioversol 350 contrast injectionAI (109 hospitals, 48,591–48,987 samples)